🇺🇸 ACs in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 11

Most-reported reactions

1. Pruritus — 2 reports (18.18%)
2. Accidental Exposure To Product — 1 report (9.09%)
3. Antiphospholipid Antibodies Positive — 1 report (9.09%)
4. Atrioventricular Block — 1 report (9.09%)
5. Chills — 1 report (9.09%)
6. Dermatitis Contact — 1 report (9.09%)
7. Eye Irritation — 1 report (9.09%)
8. Eye Pain — 1 report (9.09%)
9. Eye Swelling — 1 report (9.09%)
10. Flushing — 1 report (9.09%)

Source database →

Frequently asked questions

Is ACs approved in United States?

ACs does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ACs in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.